AAV MUTANT HAVING BRAIN-TARGETING PROPERTY Application EP-3960755-A4 European Patent Office 22 Nov 2023
Directed modified recombinant viral vectors and their use for targeted introduction of… Grant JP-7372154-B2 Japan 31 Oct 2023
Gene editing-based method of attenuating the beta-amyloid pathway Grant US-11701436-B2 United States of America 18 Jul 2023
TROPISM-MODIFIED RECOMBINANT VIRAL PARTICLES AND USES THEREOF FOR THE TARGETED… Grant EP-3645553-B1 European Patent Office 15 Mar 2023